Controlled Diets for Dietary Biomarker Identification in Healthy Adults
(P1-SDBDC Trial)
Trial Summary
What is the purpose of this trial?
This trial involves healthy adults eating specific foods like beef, beans, and eggs to help researchers find unique markers in their blood and urine. These markers will help scientists accurately measure dietary intake.
Will I have to stop taking my current medications?
The trial requires that participants stop taking certain medications, including diuretics, steroids, opiates, and some psychiatric and anti-lipid medications. Study staff will review your medications to determine eligibility, so you may need to stop taking some of your current medications.
What data supports the effectiveness of the treatment involving controlled feeding of beef and/or pinto beans?
Research shows that consuming dry beans, like pinto beans, may help reduce the risk of certain cancers, such as colon and breast cancer, by affecting cancer-related processes in the body. This suggests that including pinto beans in a diet could have health benefits related to cancer prevention.12345
Is it safe for humans to consume controlled diets including beef, pinto beans, eggs, and black beans?
Research indicates that beans, including pinto and black beans, are generally safe for human consumption and provide nutritional benefits like protein and fiber. However, some people may experience intestinal gas from beans, and it's important to ensure a balanced diet to maintain nutrient levels.25678
How is the controlled feeding study of beef and pinto beans unique compared to other treatments?
This treatment is unique because it uses a controlled diet to identify dietary biomarkers, which are indicators in the body that reflect food intake. Unlike other treatments that may focus on single nutrients, this study evaluates the combined effects of specific foods like beef and pinto beans, potentially offering a more comprehensive understanding of diet-related health impacts.49101112
Research Team
Johanna W. Lampe, PhD, RD
Principal Investigator
Fred Hutchinson Cancer Center
Marian L. Neuhouser
Principal Investigator
Fred Hutchinson Cancer Center
Eligibility Criteria
Healthy adults over 18, with a BMI of 18.5-39.9 kg/m2, who can visit the Fred Hutch campus 16 times for the study are eligible. Exclusions include those with certain gastrointestinal disorders, recent surgery or cancer treatment, substance use that they're unwilling to stop during the study, and various other health conditions and medication uses.Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Controlled Feeding Period
Participants undergo a 2-day run-in of controlled feeding followed by a 7-day feeding period for each of the three feeding periods.
Washout
A 7-day washout period between each feeding period to reset dietary intake.
Follow-up
Participants are monitored for safety and effectiveness after the feeding trials, with specimen collection for study outcomes and future studies.
Treatment Details
Interventions
- Controlled feeding study of beef and/or pinto beans (Behavioural Intervention)
- Controlled feeding study of eggs and/or black beans (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Marian Neuhouser
Lead Sponsor
United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)
Collaborator
University of Nebraska
Collaborator
Michael Dixon
University of Nebraska
Chief Executive Officer since 2010
PhD in Molecular Biology
Dr. Makker
University of Nebraska
Chief Medical Officer since 2020
MD from University of Nebraska Medical School
University of Washington
Collaborator
Dr. Timothy H. Dellit
University of Washington
Chief Executive Officer since 2023
MD from University of Washington
Dr. Anneliese Schleyer
University of Washington
Chief Medical Officer since 2023
MD, MHA
Duke University
Collaborator
Mary E. Klotman
Duke University
Chief Executive Officer since 2017
MD from Duke University School of Medicine
Michelle McMurry-Heath
Duke University
Chief Medical Officer since 2020
MD from Duke University School of Medicine